Loading…
CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in...
Saved in:
Published in: | Disease markers 2016-01, Vol.2016 (2016), p.1-9 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3 |
container_end_page | 9 |
container_issue | 2016 |
container_start_page | 1 |
container_title | Disease markers |
container_volume | 2016 |
creator | Gao, Qinglei Wu, Peng Ma, Ding Liu, Jia Gao, Peipei Gong, Song Zhang, Zeyu Zhao, Meisong Sun, Shujuan Han, Yingyan Zhou, Jianfeng |
description | Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis. |
doi_str_mv | 10.1155/2016/3528064 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4864557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A508841399</galeid><sourcerecordid>A508841399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</originalsourceid><addsrcrecordid>eNqNkUtrGzEURkVISZy0u6zDQDeFdGpdvUWgkAx9QaBetIuuhEajsVXGo0QaJ_TfV8au2-6CFkLcw-G7-hC6APwOgPM5wSDmlBOFBTtCM1CS10pQfIxmmEhVY8LwKTrL-SfGQDTTJ-iUSEI1VmqGrpsfDVSL5LvgplwtYkzlFZdjzCFXYawWdgp-LKOnMK2q2-RtnqrGjs6nl-hFb4fsX-3vc_T944dvzef67uunL83NXe2YhKlWvXDWa-awklqVU3IwR4RSLZUguYbOKecka3nPpbKSW8m4E7ztAVrc0XP0fue937Rr37kSJ9nB3KewtumXiTaY_ydjWJllfDRMCca5LII3e0GKDxufJ7MO2flhsKOPm2xAakpAcMEK-nqHLu3gTRj7WIxui5sbXn6MAdW6UG93lEsx5-T7QxjAZtuK2bZi9q0U_PLfBQ7wnxoKcLUDVmHs7FN4ps4Xxvf2Lw2YCsXpb-UKm98</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793216564</pqid></control><display><type>article</type><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><source>Wiley_OA刊</source><creator>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng</creator><contributor>Liotta, Lance A.</contributor><creatorcontrib>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng ; Liotta, Lance A.</creatorcontrib><description>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2016/3528064</identifier><identifier>PMID: 27239088</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adenosine Triphosphate - metabolism ; Adult ; AMP-Activated Protein Kinases - metabolism ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Breast cancer ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cancer patients ; Carcinoma, Ductal - metabolism ; Carcinoma, Ductal - pathology ; Cell Line, Tumor ; Cell Proliferation ; Cytochrome b ; Cytochromes c1 - genetics ; Cytochromes c1 - metabolism ; Development and progression ; Female ; Humans ; Medical research ; Medicine, Experimental ; Metastasis ; Middle Aged ; Neoplasm Metastasis ; Online databases ; Oxidative Phosphorylation ; Prognosis</subject><ispartof>Disease markers, 2016-01, Vol.2016 (2016), p.1-9</ispartof><rights>Copyright © 2016 Yingyan Han et al.</rights><rights>COPYRIGHT 2016 John Wiley & Sons, Inc.</rights><rights>Copyright © 2016 Yingyan Han et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</citedby><cites>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27239088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Liotta, Lance A.</contributor><creatorcontrib>Gao, Qinglei</creatorcontrib><creatorcontrib>Wu, Peng</creatorcontrib><creatorcontrib>Ma, Ding</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Gao, Peipei</creatorcontrib><creatorcontrib>Gong, Song</creatorcontrib><creatorcontrib>Zhang, Zeyu</creatorcontrib><creatorcontrib>Zhao, Meisong</creatorcontrib><creatorcontrib>Sun, Shujuan</creatorcontrib><creatorcontrib>Han, Yingyan</creatorcontrib><creatorcontrib>Zhou, Jianfeng</creatorcontrib><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Adult</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer patients</subject><subject>Carcinoma, Ductal - metabolism</subject><subject>Carcinoma, Ductal - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cytochrome b</subject><subject>Cytochromes c1 - genetics</subject><subject>Cytochromes c1 - metabolism</subject><subject>Development and progression</subject><subject>Female</subject><subject>Humans</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Online databases</subject><subject>Oxidative Phosphorylation</subject><subject>Prognosis</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkUtrGzEURkVISZy0u6zDQDeFdGpdvUWgkAx9QaBetIuuhEajsVXGo0QaJ_TfV8au2-6CFkLcw-G7-hC6APwOgPM5wSDmlBOFBTtCM1CS10pQfIxmmEhVY8LwKTrL-SfGQDTTJ-iUSEI1VmqGrpsfDVSL5LvgplwtYkzlFZdjzCFXYawWdgp-LKOnMK2q2-RtnqrGjs6nl-hFb4fsX-3vc_T944dvzef67uunL83NXe2YhKlWvXDWa-awklqVU3IwR4RSLZUguYbOKecka3nPpbKSW8m4E7ztAVrc0XP0fue937Rr37kSJ9nB3KewtumXiTaY_ydjWJllfDRMCca5LII3e0GKDxufJ7MO2flhsKOPm2xAakpAcMEK-nqHLu3gTRj7WIxui5sbXn6MAdW6UG93lEsx5-T7QxjAZtuK2bZi9q0U_PLfBQ7wnxoKcLUDVmHs7FN4ps4Xxvf2Lw2YCsXpb-UKm98</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Gao, Qinglei</creator><creator>Wu, Peng</creator><creator>Ma, Ding</creator><creator>Liu, Jia</creator><creator>Gao, Peipei</creator><creator>Gong, Song</creator><creator>Zhang, Zeyu</creator><creator>Zhao, Meisong</creator><creator>Sun, Shujuan</creator><creator>Han, Yingyan</creator><creator>Zhou, Jianfeng</creator><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><author>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Adult</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer patients</topic><topic>Carcinoma, Ductal - metabolism</topic><topic>Carcinoma, Ductal - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cytochrome b</topic><topic>Cytochromes c1 - genetics</topic><topic>Cytochromes c1 - metabolism</topic><topic>Development and progression</topic><topic>Female</topic><topic>Humans</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Online databases</topic><topic>Oxidative Phosphorylation</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Qinglei</creatorcontrib><creatorcontrib>Wu, Peng</creatorcontrib><creatorcontrib>Ma, Ding</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Gao, Peipei</creatorcontrib><creatorcontrib>Gong, Song</creatorcontrib><creatorcontrib>Zhang, Zeyu</creatorcontrib><creatorcontrib>Zhao, Meisong</creatorcontrib><creatorcontrib>Sun, Shujuan</creatorcontrib><creatorcontrib>Han, Yingyan</creatorcontrib><creatorcontrib>Zhou, Jianfeng</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Qinglei</au><au>Wu, Peng</au><au>Ma, Ding</au><au>Liu, Jia</au><au>Gao, Peipei</au><au>Gong, Song</au><au>Zhang, Zeyu</au><au>Zhao, Meisong</au><au>Sun, Shujuan</au><au>Han, Yingyan</au><au>Zhou, Jianfeng</au><au>Liotta, Lance A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><issue>2016</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>27239088</pmid><doi>10.1155/2016/3528064</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-0240 |
ispartof | Disease markers, 2016-01, Vol.2016 (2016), p.1-9 |
issn | 0278-0240 1875-8630 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4864557 |
source | Wiley_OA刊 |
subjects | Adenosine Triphosphate - metabolism Adult AMP-Activated Protein Kinases - metabolism Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Breast cancer Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer patients Carcinoma, Ductal - metabolism Carcinoma, Ductal - pathology Cell Line, Tumor Cell Proliferation Cytochrome b Cytochromes c1 - genetics Cytochromes c1 - metabolism Development and progression Female Humans Medical research Medicine, Experimental Metastasis Middle Aged Neoplasm Metastasis Online databases Oxidative Phosphorylation Prognosis |
title | CYC1 Predicts Poor Prognosis in Patients with Breast Cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A36%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CYC1%20Predicts%20Poor%20Prognosis%20in%20Patients%20with%20Breast%20Cancer&rft.jtitle=Disease%20markers&rft.au=Gao,%20Qinglei&rft.date=2016-01-01&rft.volume=2016&rft.issue=2016&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2016/3528064&rft_dat=%3Cgale_pubme%3EA508841399%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793216564&rft_id=info:pmid/27239088&rft_galeid=A508841399&rfr_iscdi=true |